# Kai Yeung

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kai-yeung/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,029 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 16 |
| i10-index | 24 |
| Last Known Institution | Amazon (United States) |
| OpenAlex ID | https://openalex.org/A5102920716 |
| ORCID iD | 0000-0002-1102-2040 |
| Works | 54 |

## Researcher papers

- [US Health Care Spending by Payer and Health Condition, 1996-2016](https://scholariq.org/papers/us-health-care-spending-by-payer-and-health-condition-1996-2016/)
- [Effect of Telephone Cognitive Behavioral Therapy for Insomnia in Older Adults With Osteoarthritis Pain](https://scholariq.org/papers/effect-of-telephone-cognitive-behavioral-therapy-for-insomnia-in-older-adults/)
- [Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers](https://scholariq.org/papers/current-status-and-trends-in-performance-based-risk-sharing-arrangements-between/)
- [Design, Implementation, and First-Year Outcomes of a Value-Based Drug Formulary](https://scholariq.org/papers/design-implementation-and-first-year-outcomes-of-a-value-based-drug-formulary/)
- [Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls](https://scholariq.org/papers/impact-of-the-pilot-volume-based-drug-purchasing-policy-in-china-interrupted/)
- [Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures](https://scholariq.org/papers/impact-of-a-value-based-formulary-on-medication-utilization-health-services/)
- [Using Performance-Based Risk-Sharing Arrangements to Address Uncertainty in Indication-Based Pricing](https://scholariq.org/papers/using-performance-based-risk-sharing-arrangements-to-address-uncertainty-in/)
- [Costs of using evidence‐based implementation strategies for behavioral health integration in a large primary care system](https://scholariq.org/papers/costs-of-using-evidence-based-implementation-strategies-for-behavioral-health/)
- [Adherence, Persistence, and Expenditures for High-Cost Anti-Inflammatory Drugs in Rheumatoid Arthritis: An Exploratory Study](https://scholariq.org/papers/adherence-persistence-and-expenditures-for-high-cost-anti-inflammatory-drugs-in/)
- [Asthma control, cost and race: results from a national survey](https://scholariq.org/papers/asthma-control-cost-and-race-results-from-a-national-survey/)
- [The effectiveness and value of fezolinetant for moderate-to-severe vasomotor symptoms associated with menopause: A summary from the Institute for Clinical and Economic Review’s Midwest Public Advisory Council](https://scholariq.org/papers/the-effectiveness-and-value-of-fezolinetant-for-moderate-to-severe-vasomotor/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)

## Researcher university

- [Amazon (United States)](https://scholariq.org/institutions/amazon-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.